Gemtuzumab ozogamicin Completed Phase 4 Trials for ECG / Safety / Pharmacokinetics Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03727750 | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML |